Key Developments and Trends Steering the Non-Steroidal Anti-inflammatory Drugs Market Forward: Product Innovations Transforming The Non-Steroidal Anti-Inflammatory Drugs Market
Discover trends, market shifts, and competitive outlooks for the non-steroidal anti-inflammatory drugs industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
#How Has the Non-Steroidal Anti-inflammatory Drugs Market Growth Performance Trended Historically, And What Lies Ahead?
In the past few years, the market size for non-steroidal anti-inflammatory drugs has seen a robust growth. The market is predicted to rise from a value of $20.68 billion in 2024 to $22.1 billion in 2025, experiencing a compound annual growth rate (CAGR) of 6.8%. The historic growth can be credited to factors such as chronic inflammatory ailments, pain management post-surgery, injuries related to sports, availability over-the-counter, an aging demographic and increased consumer awareness.
The market for non-steroidal anti-inflammatory drugs is anticipated to experience vigorous growth in the coming years, with a projected value of $28.79 billion in 2029, implying a compound annual growth rate (CAGR) of 6.8%. This growth during the projection period can be linked to factors such as emerging therapies in pain management, changes in regulations, the use of telehealth, trends in global wellness, competition from biosimilars, patient preferences, and precision medicine strategies. Key trends for the forecast period encompass dominance of the over-the-counter (OTC) market, a growing preference for cox-2 inhibitors, generics and market competition, and the incorporation of digital health technologies.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8023&type=smp
How Are Key Drivers in the Industry Acting as Catalysts for the Growth of the Non-Steroidal Anti-inflammatory Drugs Market?
The non-steroidal anti-inflammatory drugs market is predicted to grow due to the increasing prevalence of chronic pain. Chronic pain is described as discomfort that persists over a period of longer than six months. These non-steroidal anti-inflammatory drugs are often used to manage chronic pain and aid in injury recovery. For example, a report by the CDC (Centers for Disease Control and Prevention), a government agency in the US, noted in April 2022 that arthritis often resulted in chronic pain, impacting millions of people in the country. Roughly one out of four adults among 15 million people suffering from arthritis are said to experience severe joint pain associated with the condition. Thus, this increasing occurrence of chronic pain is contributing to the rising growth of the non-steroidal anti-inflammatory drugs market.
Which Segments in the Non-Steroidal Anti-inflammatory Drugs Offer the Most Growth?
The non-steroidal anti-inflammatory drugs market covered in this report is segmented –
1) By Route Of Administration: Oral, Topical, Other Route Of Administration
2) By Disease Indication: Arthritis, Migraine, Ophthalmic Diseases, Other Disease Indications
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
Subsegments:
1) By Oral: Tablets, Capsules, Liquids Or Solutions
2) By Topical: Gels, Creams, Patches
3) By Other Route Of Administration: Injectable (Intravenous And Intramuscular), Suppositories
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=8023&type=smp
What Are the Fastest-Growing Geographies in the Non-Steroidal Anti-inflammatory Drugs Market?
North America was the largest region in the non-steroidal anti-inflammatory drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the non-steroidal anti-inflammatory drugs market during the forecast period. The regions covered in the non-steroidal anti-inflammatory drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Current Market Growth and Trends in the Non-Steroidal Anti-inflammatory Drugs Industry?
One of the leading trends in the market for non-steroidal anti-inflammatory drugs is the focus on innovative products. The primary businesses in this market are turning their attention to the development of new technological solutions. For example, Endo International plc, a pharmaceutical company based in Ireland, introduced ibuprofen-famotidine 800 mg/26.6 mg tablets in March 2024. These tablets, which pair the pain-relieving and anti-inflammatory properties of ibuprofen with the stomach-protecting benefits of famotidine aim to manage pain while reducing the potential gastrointestinal side effects associated with extended consumption of nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen.
View the full report here:
What Are the Key Elements That Define the Non-Steroidal Anti-inflammatory Drugs Market?
Non-steroidal anti-inflammatory drugs are medications that reduce inflammation and lower a fever. They are used to treat headaches, sprains and strains, painful periods, colds and flu, arthritis, and other long-term pain conditions, and to reduce inflammation, relieve pain, and bring down a high temperature.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8023
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
